Aanastra Inc and Divincell SAS present a “Peptide-based nanoparticle platform for extrahepatic targeted delivery of mRNA and gene editing” at the 4th mRNA Based Therapeutics Summit Europe, Frankfurt. January 28-30, 2025
Aanastra Inc and Divincell SAS present a “Peptide-based nanoparticle platform for extrahepatic
28 janvier 2025
Last posts
Nos dernières parutions
- Aanastra Inc and Divincell SAS will be presenting “the PEP-NP
- Aanastra Inc and Divincell to highlight its technology in Multiple Presentations
- Aanastra Inc and Divincell Announce Presentations of Preclinical Data
- Aanastra Inc/DIVINCELL present their Peptide-based Nanoparticle platform
- Aanastra Inc/DIVINCELL present Peptide-based Nanoparticle platform
Suivez-nous
Follow us